The Anaphylaxis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Anaphylaxis has experienced robust growth in the past years. The market value will increase from $3.24 billion in 2024 to $3.51 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.4%.
The Anaphylaxis Global Market Report 2025 predicts that by 2029, the market size will reach $4.81 billion, growing at a compound annual growth rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Anaphylaxis Market Report and Uncover Key Trends Now!The key drivers in the anaphylaxis market are:
• Increasing urbanization and lifestyle changes are driving the growth of the anaphylaxis market.
• The incidence of anaphylaxis cases is growing, which is fueling the market's expansion.
• Rising disposable incomes in emerging markets are catalyzing the growth in the industry.
• Innovations in delivery systems for emergency treatment also serve as a substantial growth driver in the anaphylaxis market.
The anaphylaxis market covered in this report is segmented –
1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class
2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration
3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
Subsegments:
1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials
2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers
The key trends in the anaphylaxis market are:
• A rising demand for injectable auto-injectors is a key trend in the market.
• Incorporation of digital health solutions in managing anaphylaxis is becoming prominent.
• The trend of focusing on affordability of products is rising in the market.
• Increased emphasis on preventative treatments, vaccines, and usage of biologics for allergy treatment are defining future trends.
Major players in the anaphylaxis market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline Plc
• F. Hoffman-La Roche Ltd.
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Perrigo Company plc
• Dr Reddy’s Laboratories Ltd.
• Cipla Ltd.
• Amneal Pharmaceuticals Inc.
• Mylan N.V.
• ALK-Abelló
• Stallergenes Greer
• Allergy Therapeutics
North America was the largest region in the anaphylaxis market in 2024